In Vitro Studies with UK-18,892, a New Aminoglycoside Antibiotic

The antibacterial activity of UK-18,892, a new semisynthetic aminoglycoside, was examined against aminoglycoside-susceptible and aminoglycoside-resistant clinical isolates of gram-negative bacilli and Staphylococcus aureus. UK-18,892 had a similar degree of activity to those of amikacin and kanamyci...

Deskribapen osoa

Xehetasun bibliografikoak

Argitaratua izan da:	Antimicrob Agents Chemother
Egile Nagusiak:	Jevons, S., Cheeseman, H. E., Brammer, K. W.
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	American Society for Microbiology (ASM) 1978
Gaiak:	Physiological Effects and Microbial Susceptibility
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC352451/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/708005/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.14.3.277
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!